Meta-analysis of routine blood tests as predictors of mortality in COPD.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 4629760)

Published in Eur Clin Respir J on June 05, 2014

Authors

Frederikke K Lomholt1, Anne S Laulund2, Nina H Bjarnason3, Henrik L Jørgensen1, Nina Skavlan Godtfredsen4

Author Affiliations

1: Department of Clinical Biochemistry, Bispebjerg University Hospital, Copenhagen, Denmark.
2: Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark.
3: Department of Lung Transplantation, Rigshospitalet, Copenhagen, Denmark.
4: Department of Respiratory Medicine, Hvidovre University Hospital, Copenhagen, Denmark.

Articles cited by this

Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med (2006) 49.95

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2012) 22.96

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80

Global burden of COPD: risk factors, prevalence, and future trends. Lancet (2007) 9.50

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax (2004) 8.09

Statistics notes. The odds ratio. BMJ (2000) 5.61

Mortality in COPD: Role of comorbidities. Eur Respir J (2006) 4.14

Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89

State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail (2008) 3.35

Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes (2005) 2.42

Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax (2011) 2.39

Pharmacoeconomic evaluation of COPD. Chest (2000) 2.35

Meta-analysis: Its strengths and limitations. Cleve Clin J Med (2008) 2.15

C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest (2008) 1.98

Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med (2003) 1.91

Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J (2007) 1.85

Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest (2006) 1.75

Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med (1998) 1.70

Factors affecting survival of hospitalised patients with COPD. Eur Respir J (2005) 1.60

Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest (2003) 1.37

Anemia and performance status as prognostic markers in acute hypercapnic respiratory failure due to chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 1.21

Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med (2014) 1.20

Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey. BMC Pulm Med (2013) 1.14

Unrecognised ventricular dysfunction in COPD. Eur Respir J (2011) 1.06

Determinants of cardiac troponin T elevation in COPD exacerbation - a cross-sectional study. BMC Pulm Med (2009) 0.97

Blood transfusion facilitating difficult weaning from the ventilator. Anaesthesia (1998) 0.96

NT-proBNP independently predicts long term mortality after acute exacerbation of COPD - a prospective cohort study. Respir Res (2012) 0.94

High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD. Arch Bronconeumol (2011) 0.92

Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor. Respiration (2012) 0.92

Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure. Respir Care (2012) 0.89

Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease. Int J Cardiol (2012) 0.89

Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials. Am Heart J (2011) 0.88

Anemia and 90-day mortality in COPD patients requiring invasive mechanical ventilation. Clin Epidemiol (2010) 0.87

Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD (2012) 0.87

Anaemia in chronic obstructive pulmonary disease. Does it really matter? Int J Clin Pract (2013) 0.84

Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases. Eur J Intern Med (2013) 0.82

Correcting anemia in heart failure: the efficacy and safety of erythropoiesis-stimulating agents. J Card Fail (2010) 0.80